---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-017311"
form_type: "8-K"
ticker: "VERA"
cik: "0001831828"
company_name: "Vera Therapeutics, Inc."
filed_at: "2024-01-29T23:59:59+00:00"
generated_at: "2026-06-06T16:04:56.873898+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Vera Therapeutics reports preliminary cash of $160.7M; suspends ATM offering

## Summary
- Preliminary unaudited cash, cash equivalents and marketable securities as of Dec 31, 2023: approximately $160.7 million.
- Company suspended and terminated the ATM prospectus effective Jan 29, 2024; no further sales under current Sales Agreement until new prospectus filed.
- Estimate is unaudited and subject to change upon completion of quarter-end and year-end financial close for Q4 and FY2023.

## SEC filing metadata
- accession: 0001193125-24-017311
- form_type: 8-K
- ticker: VERA
- cik: 0001831828
- company_name: Vera Therapeutics, Inc.
- filed_at: 2024-01-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831828/000119312524017311/0001193125-24-017311-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831828/000119312524017311/d88404d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-017311
- JSON: https://secwatch.observer/filing/0001193125-24-017311.json
- Plain text: https://secwatch.observer/filing/0001193125-24-017311.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.